Vancomycin is designed to help reduce medication errors and features the company’s PreventIV Measures packaging and labeling. The injection is used to treat infections caused by susceptible strains
Humira, which works by inhibiting tumour necrosis factor-alpha (TNF-alpha), was previously approved for the treatment of moderate to severe Crohn’s disease. Abbott Global Pharmaceutical Research and Development senior
The partnership, a part of its Prime Site program, is designed to increase access to clinical trials for both patients and investigators, quickening the collection of data about
According to the merger agreement, Par’s stockholders are eligible to earn $50.00 in cash, without interest, less any applicable withholding taxes, for each share of Par common stock
The FDA has also approved the company’s ANDA for Irbesartan and Hydrochlorothiazide Tablets USP, 150/12.5mg and 300/12.5 mg, the generic version of Sanofi’s Avalide. The company announced the
Bevacizumab is a biologic antibody designed to interfere with the tumor blood supply by directly binding to a protein called VEGF and helps curing recurrent glioblastoma while TH-302
Abstract #1245 studies were designed to study advanced NSCLC chemotherapy-naive patients treated with ramucirumab in combination with first-line ALIMTA (pemetrexed for injection)/platinum-based chemotherapy while Abstract#1287 studied patients treated
The Cardiashred, which has 32 ingredients including omega 3’s (fish source), CoQ10, betaine and piperine, grape seed extract, is designed to help all adults manage their weight, be
Under the contract, Lonza will supply the preclinical study material for the drug optimization and drug selection for Intellect’s Conjumab-A, aiming on age-related macular degeneration (AMD) with potential
Somatoprim, which is currently in phase I of clinical development, is a new molecular entity somatostatin analogue which is proved in treating Acromegaly, carcinoid tumours, and Cushing’s disease,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.